OICR researchers

OICR supports approximately 1,900 highly qualified personnel at institutions across the province of Ontario. This page lists the recipients of OICR Investigator Awards, Associates, Affiliates, research fellows and the leaders of OICR’s research programs and initiatives. Find out more about OICR’s Investigator Awards Program.

Sagi Abelson

Dr. Abelson studies the extrinsic selective pressures and cell-intrinsic mechanisms governing clonal dominance and cell transformation.

More details about Dr. Abelson→

Laurie Ailles

Dr. Ailles and her team are focusing on two major research areas: intra-tumoural heterogeneity and epigenetics in clear cell renal cell carcinoma.

More details about Dr. Ailles→

Rima Al-awar

Dr. Al-awar, Head of Therapeutic Innovation and Drug Discovery, discovers and develops new drugs for various cancers in collaboration with both academic and industry partners.

More details about Dr. Al-awar→

Philip Awadalla

Dr. Awadalla and his team focus on the development of genomics approaches, model-based tools and population-based approaches to study mutation rates, genome biology and cancer.

More details about Dr. Awadalla→

John Bartlett

Dr. Bartlett and his team focus on the development of novel diagnostic approaches to stratified medicine, predominantly in breast and prostate cancer.

More details about Dr. Bartlett→

Philippe Bedard

Dr. Bedard is working to bring next-generation sequencing to more Ontario cancer patients through the Ontario-wide Cancer TArgeted Nucleic Acid Evaluation (OCTANE) study.

More details about Dr. Bedard→

John Bell

John Bell

Dr. Bell’s lab is developing novel oncolytic virus products that both kill cancer cells while stimulating anti-tumour immunity.

More details about Dr. Bell→

Marcus Butler

Dr. Butler is the clinical lead of OICR’s Immuno-oncology Translational Research Initiative (ACTION). His expertise includes clinical trials in a variety of immune therapies.

More details about Dr. Butler→

Tricia Cottrell

Tricia Cottrell

Dr. Tricia Cottrell is a clinician scientist whose research focuses on tumour-immune interactions in solid tumours.

More details about Dr. Cottrell→

Janet Dancey

Dr. Janet Dancey is the leader of the Canadian Cancer Clinical Trials Network and the Canadian Cancer Trials Group.

More details about Dr. Dancey→

John Dick

Dr. Dick, who co-leads OICR’s Acute Leukemia Translational Research Initiative, is a pioneer in cancer stem cell biology.

More details about Dr. Dick→

Peter Dirks

Dr. Dirks is a pediatric neurosurgeon and senior scientist at the Hospital for Sick Children. He co-leads OICR’s Brain Cancer Translational Research Initiative.

More details about Dr. Dirks→

Aaron Fenster

Dr. Fenster is driven by the opportunity to use technological innovations to meet the challenges of cancer diagnosis and therapy needs. He co-leads OICR’s Imaging program.

More details about Dr. Fenster→

Geoffrey T. Fong

Dr. Fong is the founder of the International Tobacco Control Policy Evaluation Project. This project’s objective is to evaluate the impact of policies designed to control tobacco use.

More details about Dr. Fong→

Steven Gallinger

Dr. Gallinger is Head, Clinical Translation, OICR and co-leads OICR’s Pancreatic Cancer Translational Research Initiative (PanCuRx)

More details about Dr. Gallinger→

Eva Grunfeld

The focus of Dr. Grunfeld’s research is the evaluation of access to and quality of cancer care across the cancer control continuum – from screening to end-of-life care.

More details about Dr. Grunfeld→

Bishal Gyawali

Dr. Gyawali’s areas of interest include cancer policy, evidence-based oncology, financial toxicities of cancer treatment, clinical trial methods, supportive care and global oncology.

More details about Dr. Gyawali

Masoom Haider

Dr. Haider’s research focus is abdominal and pelvic MRI with an interest in therapeutic response assessment and quantitative imaging of cancer.

More details about Dr. Haider→

Timothy Hanna

Dr. Hanna’s research focuses on three translational streams of health services research: quality of care, value of care and access to care.

More details about Dr. Hanna→

Naoto Hirano

The overarching goal of Dr. Hirano’s research is to devise novel anti-tumour immunotherapeutic modalities that can cure cancer.

More details about Dr. Hirano→

Kristin Hope

Dr. Hope aims to identify the underlying processes that lead to the transformation of healthy cells into leukemic cells and contribute to the progression of the disease.

More details about Dr. Hope→

Hartland Jackson

Hartland Jackson

Dr. Jackson aims to understand the formation and evolution of tissues and tumours as multi-cell systems.

More details about Dr. jackson→

Tamara Jamaspishvili

Dr. Jamaspishvili is working to identify and validate promising diagnostic and prognostic biomarkers for early prostate cancer.

More details about Dr. Jamaspishvili→

Courtney Jones

Courtney Jones

Dr. Jones’ research focuses on improving outcomes for patients with leukemia.

More details about Dr. Jones→

David LeBrun

Dr. LeBrun’s research group studies perturbations in the regulation of gene transcription that underlie acute lymphoblastic leukemia and other cancers.

More details about Dr. LeBrun→

Mathieu Lupien

Dr. Lupien’s research highlights the need to characterize and understand the role of noncoding regulatory elements as targets of genetic and epigenetic changes in oncogenesis.

More details about Dr. Lupien→

Brian Nieman

Dr. Nieman is studying the developmental impact of chemotherapy agents with a goal of improved brain development and quality of life in childhood cancer patients.

More details about Dr. Nieman→

Faiyaz Notta

Dr. Notta co-leads OICR’s Pancreatic Cancer Translational Research Initiative (PanCuRx).

More details about Dr. Notta→

Amit Oza

Dr. Oza co-leads OICR’s Ovarian Cancer Translational Research Initiative and specializes in clinical trials for gynecologic cancers.

More details about Dr. Oza→

David Palma

Dr. Palma’s research focuses on new imaging technologies used with radiotherapy to improve tumour targeting and to deliver higher doses of radiotherapy than previously possible.

More details about Dr. Palma→

Shraddha Pai

Shraddha Pai

Dr. Pai works to enable precision medicine by discovering multi-omic signatures for data-driven clinical decision-making.

More details about Dr. Pai→

Anna Panchenko

Anna Panchenko

Dr. Panchenko’s research group studies the genetic and epigenetic mechanisms of cancer, including the effects of mutations on protein activity, interactions and dynamics.

More details about Dr. Panchenko→

Bret Pearson

Dr. Pearson’s lab is working to understand the connection between adult stem cells and cancer by using the freshwater planarian as an in vivo model system.

More details about Dr. Pearson→

Gregory Pond

Dr. Pond’s research interest is in statistical methodologies and analysis of cancer clinical trials, with an aim to facilitate the translation of scientific discoveries into the clinic.

More details about Dr. Pond→

Trevor Pugh

Dr. Pugh is the Director of Genomics at OICR.

More details about Dr. Pugh→

Jüri Reimand

The Reimand Lab develops and applies methods to interpret cancer data using pathway and network information.

More details about Dr. Reimand→

Robert Rottapel

The Rottapel Lab uses functional genetic screens (both shRNA and CRISPR/Cas9) to identify novel vulnerabilities in ovarian cancer as a strategy to develop new therapeutic targets.

More details about Dr. Rottapel→

Aaron Schimmer

Dr. Schimmer is the co-leader of OICR’s Acute Leukemia Translational Research Initiative. His work focuses on new therapies for leukemia.

More details about Dr. Schimmer→

Timothy Scholl

Dr. Scholl is focusing on developing an emergent technique for molecular imaging with magnetic resonance.

More details about Dr. Scholl→

Parisa Shooshtari

Parisa Shooshtari

Dr. Shooshtari develops computational and statistical methods to understand the cellular and molecular mechanisms of complex diseases.

More details about Dr. Shooshtari→

Jared Simpson

The Simpson Lab develops algorithms and software for the analysis of high-throughput sequencing data.

More details about Dr. Simpson→

Lillian Siu

Dr. Siu is Co-Principal Investigator of the Ontario-wide Cancer TArgeted Nucleic Acid Evaluation (OCTANE) study.

More details about Dr. Siu→

Lincoln Stein

Lincoln Stein

Dr. Stein is the leader of Adaptive Oncology at OICR.

More details about Dr. Stein→

Michael Taylor

Dr. Taylor is a paediatric neurosurgeon and senior scientist at the Hospital for Sick Children. He co-leads OICR’s Brain Cancer Translational Research Initiative.

More details about Dr. Taylor→

Anastasia Tikhonova

Dr. Tikhonova is an OICR Investigator delineating the mechanisms that underlie dysregulated crosstalk between leukemic cells and their niche.

More details about Dr. Tikhonova→

Brad Wouters

Dr. Wouters’ lab has identified new signaling pathways that influence how tumours respond to environments with reduced oxygenation.

More details about Dr. Wouters→

Martin Yaffe

Dr. Yaffe’s research is directed toward development and improvement of imaging techniques for the earlier detection, diagnosis and treatment of cancer.

More details about Dr. Yaffe→

Christina Yung

Dr. Yung is the Director of Genome Informatics at OICR.

More details about Dr. Yung→

OICR Associates and Affiliates

Yvonne Bombard

Yvonne Bombard
OICR Associate

Scientist, Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Unity Health Toronto

More details about Yvonne Bombard

Kieran Campbell
OICR Affiliate

Scientist & Principal Investigator, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital

Assistant Professor, University of Toronto

More details about Kieran Campbell

Harriet Feilotter
OICR Associate

Molecular Geneticist and Scientist, Kingston Health Sciences Centre
Faculty Member, Queen’s Cancer Research Institute

More details about Harriet Feilotter

Vincent Ferretti
OICR Associate

Researcher, CHU Sainte-Justine

Professor-Researcher, Faculty of Medicine, University of Montreal

Director, Digital Platforms, Genome Quebec

More details about Vincent Ferretti

Marc Fiume
OICR Associate

CEO, DNAstack

More details about Marc Fiume

Michael Fraser

Michael Fraser
OICR Affiliate

Scientific Director, The Canadian Prostate Cancer Genome Network (CPC-GENE)

Assistant Professor, Faculty of Medicine, University of Toronto

Staff Scientist, Princess Margaret Cancer Centre, University Health Network

More details about Michael Fraser

Benjamin Haibe-Kains
OICR Associate

Senior Scientist, Princess Margaret Cancer Centre, University Health Network

Associate Professor, Department of Medical Biophysics, University of Toronto

Adjunct Assistant Professor, Department of Computer Science, University of Toronto

Affiliate, Vector Institute

More details about Benjamin Haibe-Kains

Elizabeth Kornaga
OICR Associate

Translational Scientist, Tom Baker Cancer Centre

More details about Elizabeth Kornaga

Quaid Morris
OICR Associate

Member, Computational & Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center

More details about Quaid Morris

Rola Saleeb

Rola Saleeb
OICR Associate

Director of the Immunopathology Laboratory, St. Michael’s Hospital, Unity Health Toronto

Anatomical Pathologist, St. Michael’s Hospital and Li Ka Shing Knowledge Institute

Assistant Professor, Laboratory Medicine and Pathobiology, University of Toronto

More details about Rola Saleeb

David Soave
OICR Associate

Assistant Professor, Wilfrid Laurier University

More details about David Soave

As of October 5, 2020